Meeting
2019 ASCO Annual Meeting
Early progression of disease (POD24) as survival predictor in MALT lymphoma.
Authors
Annarita Conconi
Hematology Division, Ospedale Degli Infermi, Biella, Italy
Annarita Conconi , Catherine Thieblemont , Luciano Cascione , Valter Torri , Barbara Kiesewetter , Gloria Margiotta-Casaluci , Gianluca Gaidano , Markus Raderer , Franco Cavalli , Armando Lopez-Guillermo , Peter W. M. Johnson , Emanuele Zucca
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Track
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Sub Track
Non-Hodgkin Lymphoma
Citation
J Clin Oncol 37, 2019 (suppl; abstr 7548)
DOI
10.1200/JCO.2019.37.15_suppl.7548
Abstract #
7548
Poster Bd #
302
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Development and validation of a prognostic nomogram to predict overall survival (OS) in platinum-resistant ovarian cancer (PROC): An AURELIA substudy.
First Author: Chee Lee
Poster
2013 ASCO Annual Meeting
Correlation of chemotherapy delivery and survival outcomes of follicular lymphoma in the immunchemotherapy era.
First Author: Kitsada Wudhikarn
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Serum angiopoietin-like protein 2 level in patients who received bevacizumab-containing chemotherapy for metastatic colorectal cancer.
First Author: Jung Hoon Kim
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world evaluation of clinical outcomes and long-term survivors in patients with BRAF-V600E metastatic colorectal cancer.
First Author: William Phillips